Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Summary In 2018, the US National Institute on Aging and the Alzheimer's Association
proposed a purely biological definition of Alzheimer's disease that relies on biomarkers …
proposed a purely biological definition of Alzheimer's disease that relies on biomarkers …
[HTML][HTML] The China alzheimer report 2022
R Ren, J Qi, S Lin, X Liu, P Yin, Z Wang, R Tang… - General …, 2022 - ncbi.nlm.nih.gov
China's population has rapidly aged over the recent decades of social and economic
development as neurodegenerative disorders have proliferated, especially Alzheimer's …
development as neurodegenerative disorders have proliferated, especially Alzheimer's …
The characterisation of subjective cognitive decline
A growing awareness about brain health and Alzheimer's disease in the general population
is leading to an increasing number of cognitively unimpaired individuals, who are concerned …
is leading to an increasing number of cognitively unimpaired individuals, who are concerned …
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Various biomarkers are available to support the diagnosis of neurodegenerative diseases in
clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET …
clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET …
Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review
Y Chen, Y Wang, Z Song, Y Fan, T Gao… - Ageing Research Reviews, 2023 - Elsevier
Alzheimer's disease (AD) is a degenerative neurological disease in elderly individuals.
Subjective cognitive decline (SCD), mild cognitive impairment (MCI) and further …
Subjective cognitive decline (SCD), mild cognitive impairment (MCI) and further …
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based …
IMW Verberk, MB Laarhuis… - The lancet Healthy …, 2021 - thelancet.com
Background Serum glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) are
putative non-amyloid blood-based biomarkers indicative of ongoing inflammatory and …
putative non-amyloid blood-based biomarkers indicative of ongoing inflammatory and …
Research criteria for the behavioral variant of Alzheimer disease: a systematic review and meta-analysis
Importance The behavioral variant of Alzheimer disease (bvAD) is characterized by early
and predominant behavioral deficits caused by AD pathology. This AD phenotype is …
and predominant behavioral deficits caused by AD pathology. This AD phenotype is …
Functional cognitive disorders: a systematic review
Cognitive symptoms are common, and yet many who seek help for cognitive symptoms
neither have, nor go on to develop, dementia. A proportion of these people are likely to have …
neither have, nor go on to develop, dementia. A proportion of these people are likely to have …